Skip to main content
BICYCLE THERAPEUTICS PLC logo

BICYCLE THERAPEUTICS PLC — Investor Relations & Filings

Ticker · BCYC ISIN · US0887861088 LEI · 213800XKUI6R7GKC3E43 US Manufacturing
Open in API
Filings indexed 598 across all filing types
Latest filing 2019-05-15 Regulatory Filings
Country GB United Kingdom
Listing US BCYC

About BICYCLE THERAPEUTICS PLC

https://www.bicycletherapeutics.com/

Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines known as Bicycle® molecules. These are fully synthetic bicyclic peptides engineered to combine the targeting specificity and pharmacological properties of large molecule biologics with the rapid and deep tissue penetration of small molecules. The company's proprietary platform creates precision-guided therapeutics to address diseases underserved by existing treatments. The primary focus of its development pipeline is in oncology, with a portfolio of candidates designed to target solid tumors. Beyond oncology, Bicycle Therapeutics leverages its technology through collaborations to explore applications in other therapeutic areas, including anti-infectives, cardiovascular diseases, and central nervous system disorders.

Recent filings

Filing Released Lang Actions
S-1/A
Regulatory Filings Classification · 95% confidence The document is an Amendment No. 2 to a Form S-1 Registration Statement filed with the SEC. Form S-1 is used for registration of securities for public offerings, typically IPOs or other public offerings. The text includes details about registration fees, indemnification of directors and officers, recent sales of unregistered securities, and exhibits. It does not contain financial statements or quarterly/yearly financial results, nor is it a transcript, proxy, or governance report. It is a regulatory filing related to capital raising but is not a direct capital/financing update or earnings release. Given the nature of the document as a registration statement amendment filed with the SEC, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2019-05-15 English
Regulatory Filings 2019
Regulatory Filings Classification · 100% confidence The document is a Form F-6 Registration Statement filed with the SEC, which is used to register American Depositary Shares (ADSs) evidenced by American Depositary Receipts (ADRs). It includes details about the securities to be registered, the deposit agreement, signatures of officers and directors, and legal opinions. The document is not a financial report, earnings release, or management discussion, but a regulatory filing related to securities registration under the Securities Act of 1933. It does not contain financial statements or analysis but is a formal registration statement for securities issuance.
2019-05-13 English
Regulatory Filings 2019
Regulatory Filings Classification · 95% confidence The document is a letter from the company responding to comments from the SEC staff regarding a Registration Statement on Form S-1. It includes references to amendments to the Registration Statement and addresses regulatory comments. The document is not a financial report, earnings release, or any other type of report but rather a regulatory correspondence related to the registration process for securities. It is a regulatory filing responding to SEC comments, which fits the category of Regulatory Filings (RNS). The document length is short (3510 characters) and is a letter, not a report or announcement of a report publication.
2019-05-13 English
S-1/A
Capital/Financing Update Classification · 100% confidence The document is an SEC filing titled 'Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933' for Bicycle Therapeutics Limited. It includes details about an initial public offering (IPO) of American Depositary Shares (ADSs), underwriting information, risk factors, use of proceeds, capitalization, dilution, management discussion and analysis, executive compensation, and other typical IPO prospectus sections. The S-1 form is used for registration of securities for public offering, which is a capital raising activity. This is not a financial report, earnings release, or management discussion report, but a registration statement related to capital markets activity. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed offering information, not just an announcement or a brief notice, so it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS).
2019-05-13 English
Regulatory Filings 2019
Regulatory Filings
2019-05-07 English
Regulatory Filings 2019
Regulatory Filings Classification · 95% confidence The document is a letter from the company's legal counsel to the SEC staff regarding a Draft Registration Statement on Form S-1. It discusses valuation methodologies for the company's ordinary shares in connection with the registration and offering process. The document references the Registration Statement on Form S-1, which is a filing related to an initial public offering (IPO). The content is focused on providing supplemental information and valuation details to the SEC staff rather than presenting financial results or management discussion. It is not an earnings release, annual report, or interim report. It is also not a proxy, voting results, or governance document. The letter is a regulatory communication related to the registration process and valuation disclosures for the offering. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory communications and filings that do not fit other specific categories.
2019-05-01 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.